Contact Us
Subscribe
e-Edition

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

32°
- Kane, PA (16735)
  Today
  
  Freezing drizzle this morning...then cloudy late. High 39F. Winds WSW at 5 to 10 mph..
  
  Tonight
  
  Overcast. Low 27F. Winds WNW at 10 to 20 mph.
  
  Updated: December 23, 2025 @ 10:39 am
- Full Forecast

Site search

Home
News
Sports
Obituaries
Local Events
- Promote Your Event
Photos
e-Edition
Classifieds
- Place an ad
Archives

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

NovaBay Pharmaceuticals, Inc. Common Stock (NY:NBY)

4.548 -0.882 (-16.24%)

Streaming Delayed Price Updated: 12:18 PM EST, Dec 23, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about NovaBay Pharmaceuticals, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

NovaBay Pharmaceuticals Targets New Market with Antimicrobial Avenova® Lid and Lash Spray for Lash Extensions

July 28, 2022

From NovaBay Pharmaceuticals, Inc.

Via Business Wire

NovaBay Pharmaceuticals’ DERMAdoctor Products Now Available at Target.com and Urbanoutfitters.com

July 21, 2022

From NovaBay Pharmaceuticals, Inc.

Via Business Wire

NovaBay Pharmaceuticals Reports Record Avenova® Sales During Amazon’s Prime Day Event

July 15, 2022

From NovaBay Pharmaceuticals, Inc.

Via Business Wire

NovaBay Pharmaceuticals’ DERMAdoctor Products to be Featured at Leading B2B Beauty Trade Show Cosmoprof North America

July 07, 2022

From NovaBay Pharmaceuticals, Inc.

Via Business Wire

NovaBay Pharmaceuticals: Q1 Earnings Insights ↗

May 12, 2022

NovaBay Pharmaceuticals (AMEX:NBY) reported its Q1 earnings results on Thursday, May 12, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Via Benzinga

NovaBay Pharmaceuticals Reports First Quarter 2022 Financial Results

May 12, 2022

From NovaBay Pharmaceuticals, Inc.

Via Business Wire

Earnings Outlook For NovaBay Pharmaceuticals ↗

May 11, 2022

NovaBay Pharmaceuticals (AMEX:NBY) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that...

Via Benzinga

NovaBay Pharmaceuticals Expands Top-Selling DERMAdoctor Kakadu C and Calm Cool + Corrected Collections with New Anti-Aging Formulations

May 09, 2022

From NovaBay Pharmaceuticals, Inc.

Via Business Wire

NovaBay Pharmaceuticals to Hold First Quarter 2022 Conference Call on May 12

May 05, 2022

From NovaBay Pharmaceuticals, Inc.

Via Business Wire

NovaBay Pharmaceuticals CEO Issues Letter to Stockholders

April 25, 2022

From NovaBay Pharmaceuticals, Inc.

Via Business Wire

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

April 21, 2022

Rise and shine! We're gearing up for another busy day of trading with a breakdown of the biggest pre-market stock movers for Thursday!

Via InvestorPlace

26 Stocks Moving in Thursday's Pre-Market Session ↗

April 21, 2022

Gainers Redbox Entertainment Inc. (NASDAQ: RDBX) rose 31.9% to $3.35 in pre-market trading after jumping around 25% on Wednesday. Clarus Therapeutics Holdings, Inc. (NASDAQ:...

Via Benzinga

23 Stocks Moving in Tuesday's Pre-Market Session ↗

April 19, 2022

Gainers ToughBuilt Industries, Inc. (NASDAQ: TBLT) rose 44.9% to $0.2125 in pre-market trading as the company posted a narrower FY21 loss. Sharps Technology, Inc. (NASDAQ: STSS...

Via Benzinga

NovaBay Pharmaceuticals Chief Product Officer Dr. Audrey Kunin Returns to QVC® to Discuss DERMAdoctor’s Eczema Treatment

April 11, 2022

From NovaBay Pharmaceuticals, Inc

Via Business Wire

NovaBay Pharmaceuticals Introduces Hydrating Cleansing Oil to its DERMAdoctor Calm Cool + Corrected Product Line

April 01, 2022

From NovaBay Pharmaceuticals, Inc.

Via Business Wire

NovaBay Pharmaceuticals's Return On Capital Employed Insights ↗

March 30, 2022

According to Benzinga Pro data, during Q4, NovaBay Pharmaceuticals (AMEX:NBY) posted sales of $2.64 million. Earnings were up 93.1%, but NovaBay Pharmaceuticals still reported an overall loss of...

Via Benzinga

NovaBay Pharmaceuticals Reports 2021 Fourth Quarter and Full Year Financial Results

March 29, 2022

From NovaBay Pharmaceuticals, Inc.

Via Business Wire

The Daily Biotech Pulse: Sanofi-IGM Ink Antibody Drug Collaboration; NeoGenomics Sinks On CEO Departure, Q1 Warning; Decision Day For Akebia ↗

March 29, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

NovaBay Pharmaceuticals Earnings Preview ↗

March 28, 2022

NovaBay Pharmaceuticals (AMEX:NBY) is set to give its latest quarterly earnings report on Tuesday, 2022-03-29. Here's what investors need to know before the announcement. Analysts estimate that NovaBay...

Via Benzinga

Earnings Scheduled For March 29, 2022 ↗

March 29, 2022

Companies Reporting Before The Bell • 36KR Holdings (NASDAQ:KRKR) is projected to report quarterly loss at $0.02 per share on revenue of $15.62 million.

Via Benzinga

NovaBay Pharmaceuticals to Hold 2021 Fourth Quarter and Full Year Conference Call on March 29

March 22, 2022

From NovaBay® Pharmaceuticals, Inc.

Via Business Wire

The Week Ahead In Biotech (March 27-April 2): Lipocine, Akebia, Merck Await FDA Verdicts, Adcom Test For Amylyx, BioNTech Earnings And More ↗

March 27, 2022

Biotech stocks reversed course in the week ending March 25, as an increase in risk appetite prompted traders to move money out of defensives and into risky bets.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

March 18, 2022

Good morning, trader! Let's start off the final day of the workweek right with a breakdown of the biggest pre-market stock movers for Friday!

Via InvestorPlace

25 Stocks Moving in Friday's Pre-Market Session ↗

March 18, 2022

Gainers Grom Social Enterprises, Inc. (NASDAQ: GROM) rose 60.5% to $1.53 in pre-market trading. StoneCo Ltd. (NASDAQ: STNE) shares rose 23.7% to $11.90 in pre-market trading...

Via Benzinga

NovaBay Pharmaceuticals Chief Product Officer Dr. Audrey Kunin to Present DERMAdoctor Eczema Treatment as QVC® On-Air Guest

February 28, 2022

From NovaBay Pharmaceuticals, Inc.

Via Business Wire

NovaBay Pharmaceuticals Engages Leading Chinese Marketing Firm to Drive Consumer Sales of DERMAdoctor Skincare Products in China

February 23, 2022

From NovaBay Pharmaceuticals, Inc

Via Business Wire

NovaBay Pharmaceuticals Announces Changes to Its Board of Directors

January 28, 2022

From NovaBay Pharmaceuticals, Inc.

Via Business Wire

NovaBay Pharmaceuticals to Donate 2.5 Million KN95 Masks

January 20, 2022

From NovaBay Pharmaceuticals, Inc.

Via Business Wire

NovaBay Pharmaceuticals Announces the Further Adjournment of the Special Meeting of Stockholders

January 20, 2022

From NovaBay Pharmaceuticals, Inc.

Via Business Wire

NovaBay Pharmaceuticals Expands Its Eyecare Product Portfolio With the Launch of Lubricating Eye Drops for the Immediate Relief of Dry Eye Symptoms

January 10, 2022

From NovaBay Pharmaceuticals, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

News
Sports
Entertainment
Local Events
Obituaries
Multimedia
Online Features

Services

Subscription Services
Submission Forms
Classifieds
Place an Ad
Promote Your Event
Email Alerts
Search
Weather

The Kane Republican

KaneRepublican.com
200 North Fraley
Kane, PA 16735
Phone: 814-837-6000
Email: krnews1@zitomedia.net

Facebook

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Kane, PA (16735)

Today

Tonight

NovaBay Pharmaceuticals, Inc. Common Stock (NY:NBY)

All News about NovaBay Pharmaceuticals, Inc. Common Stock

Sections

Services

The Kane Republican